The development of adjuvants involves a rigorous process of research and testing. Initially, potential adjuvants are identified through preclinical studies that test their efficacy and safety in animal models. Successful candidates then progress to clinical trials involving human subjects. These trials are conducted in phases to ensure the adjuvant's safety, efficacy, and optimal dosage.
